PMH11 PROBABILISTIC COST-EFFECTIVENESS ANALYSIS OF ESCITALOPRAM VERSUS CITALOPRAM IN THE TREATMENT OF SEVERE DEPRESSION IN THE UNITED KINGDOM
Abstract
Authors
ME Hemels I Toumi AG Wade
ME Hemels I Toumi AG Wade
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now